PAZOPANIB for Malignant connective tissue neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 417 adverse event reports in the FDA FAERS database where PAZOPANIB was used for Malignant connective tissue neoplasm.

Most Reported Side Effects for PAZOPANIB

Side Effect	Reports	%	Deaths	Hosp.
Death	3,767	17.8%	3,764	211
Diarrhoea	2,907	13.7%	213	501
Fatigue	1,883	8.9%	173	315
Nausea	1,879	8.9%	192	413
Malignant neoplasm progression	1,471	6.9%	570	372
Drug ineffective	1,135	5.4%	160	141
Decreased appetite	1,116	5.3%	196	321
Vomiting	1,072	5.1%	153	366
Hypertension	1,004	4.7%	104	271
Malaise	764	3.6%	148	254
Disease progression	739	3.5%	185	82
Asthenia	727	3.4%	161	280
Product use in unapproved indication	724	3.4%	153	60
Weight decreased	697	3.3%	85	168
Hair colour changes	679	3.2%	41	83